Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.5 USD | -2.27% | +0.92% | -8.42% |
04-30 | Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise | MT |
04-30 | Transcript : Harmony Biosciences Holdings, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.42% | 1.71B | |
+40.00% | 723B | |
+34.28% | 595B | |
-3.73% | 369B | |
+20.32% | 332B | |
+2.83% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
+0.00% | 168B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Harmony Biosciences Names Jeffrey Dayno Interim Chief Executive as John Jacobs Steps Down